- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05513911
Intermittent Hypoxia and Upper Extremity EMG Recordings in Individuals With Spinal Cord Injury
August 22, 2022 updated by: Milap Sandhu, Shirley Ryan AbilityLab
Intermittent Hypoxia and Upper Limb Training in Individuals With Spinal Cord Injury
In this current study, the examiners examine some of the mechanisms of how Acute Intermittent Hypoxia (AIH) effects the upper extremity of survivors of spinal cord injury.
This is accomplished both with the use of a load cell to determine elbow strength changes and high density grid electromyography (EMG) to record bicep muscle activations before and after bouts of AIH
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
It has been shown previously that there is an increase in strength in survivors of spinal cord injury after brief bouts of Acute Intermittent Hypoxia.
In this study, participants are fitted with a high density EMG electrode on the biceps brachii, and attached to a load cell at the wrist, they are asked to flex and extend their elbow at various levels of intensity.
This is performed before and after the 30 minute session of AIH.
The investigators hope to identify specific types of motor units of the upper extremity of survivors of spinal cord injury after AIH to help further our understanding of what mechanisms may be causing the known increase in muscle strength post AIH
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Shirley Ryan Abilitylab
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- History of Spinal Cord Injury from C3-T4
- Non-progressive spinal cord injury
- More than 6 months since initial Spinal Cord injury
- Ability to understand and willingness to sign written informed consent
Exclusion Criteria:
- Presence of any of the following medical conditions: Congestive heart failure, arrhythmia, uncontrolled high blood pressure, uncontrolled diabetes mellitus, COPD/emphysema and severe asthma
- Persons with known coronary artery disease, a history of myocardial infarction, or known carotid or intracerebral artery stenosis
- Medical clearance will be required if participant is taking any other investigational agents
- Women who are pregnant or nursing
- Individuals with tracheostomy
- Cannot pursue other research studies which may interfere
- Unable to consent
- Individuals who are not yet adults (infants, children, teenagers)
- Prisoners
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Acute intermittent Hypoxia Therapy
This group will receive the acute intermittent hypoxia therapy (9% O2) for 30 minutes.
Before and after the intervention the participant will perform flexion of the elbow at various levels of intensity
|
Acute Intermittent Hypoxia is administered in 30-60 second bouts of 9% O2 concentration, followed by 60-90 seconds of normoxic air concentrations (21% O2, room air).
This procedure is repeated 15 times for a 30 minute session
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Maximal Elbow Strength [Newtons]
Time Frame: 30 minutes Post intervention
|
Recordings of the elbow joint torque are taken while the participant is asked to flex and extend the elbow voluntarily at a maximum level of intensity
|
30 minutes Post intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Biceps Brachii Muscle activation [μv]
Time Frame: 30 minutes post intervention
|
Peak electromyographic activation of the biceps brachii muscle during maximum voluntary flexion and extension tasks
|
30 minutes post intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: William Z Rymer, MD, PhD, Shirley Ryan Abilitylab
- Principal Investigator: Milap Sandhu, PhD, Shirley Ryan Abilitylab
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 3, 2016
Primary Completion (Actual)
November 8, 2016
Study Completion (Actual)
March 25, 2019
Study Registration Dates
First Submitted
August 22, 2022
First Submitted That Met QC Criteria
August 22, 2022
First Posted (Actual)
August 24, 2022
Study Record Updates
Last Update Posted (Actual)
August 24, 2022
Last Update Submitted That Met QC Criteria
August 22, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00201602
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Overall participant Data will be reported in publications
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.